pyridoxal phosphate has been researched along with Hemangioma in 7 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Hemangioma: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lesions in hepatocellular carcinomas patients showed a non-homogeneous enhancement pattern." | 1.33 | Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. ( Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E, 2006) |
| "Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement." | 1.31 | MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, LJ | 1 |
| Burkill, GJ | 1 |
| Scurr, ED | 1 |
| Vlavianos, P | 1 |
| Murray-Lyons, I | 1 |
| Healy, JC | 1 |
| Chung, JJ | 2 |
| Kim, MJ | 1 |
| Kim, KW | 1 |
| Karabacakoğlu, A | 1 |
| Adigüzel, Y | 1 |
| Karaköse, S | 1 |
| Kayaçetin, E | 1 |
| Haykir, R | 1 |
| Kettritz, U | 1 |
| Schlund, JF | 1 |
| Wilbur, K | 1 |
| Eisenberg, LB | 1 |
| Semelka, RC | 2 |
| Martin, DR | 1 |
| Balci, NC | 1 |
| Wilber, K | 1 |
| Helmberger, TK | 1 |
| Laubenberger, J | 1 |
| Rummeny, E | 1 |
| Jung, G | 1 |
| Sievers, K | 1 |
| Döhring, W | 1 |
| Meurer, K | 1 |
| Reiser, MF | 1 |
| Bernardino, ME | 1 |
2 trials available for pyridoxal phosphate and Hemangioma
| Article | Year |
|---|---|
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast | 2002 |
5 other studies available for pyridoxal phosphate and Hemangioma
| Article | Year |
|---|---|
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod | 2002 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado | 1996 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia | 2000 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms | 1991 |